Location History:
- St. Louis, MO (US) (1995 - 2005)
- Kirkwood, MO (US) (2003 - 2006)
Company Filing History:
4 out of 1,323 
2 out of 200 
1 out of 2,538 Years Active: 1995-2006
Title: Celebrating the Innovations of Inventor Richard John Lindmark
Introduction:
Richard John Lindmark is a distinguished inventor hailing from St. Louis, MO, whose contributions have significantly impacted the field of anticoagulant therapy. With a remarkable portfolio of seven patents to his name, Lindmark's work exemplifies the transformative power of innovation in advancing healthcare solutions.
Latest Patents:
Lindmark's latest patents revolve around the development of substituted polycyclic aryl and heteroaryl pyrazinones. These compounds serve as crucial inhibitors of serine proteases within the coagulation cascade, offering new avenues for anticoagulant therapy in treating and preventing various thrombotic conditions such as coronary artery and cerebrovascular diseases.
Career Highlights:
Throughout his career, Lindmark has lent his expertise to renowned companies in the pharmaceutical industry. He has made significant contributions at G.D. Searle & Company and Pharmacia Corporation, where his innovative spirit and commitment to advancing healthcare solutions have left a lasting impact.
Collaborations:
Lindmark's collaborative efforts with coworkers such as Joseph Gerace Rico and Michael S. South have been instrumental in bringing his groundbreaking inventions to fruition. Together, they have worked tirelessly to push the boundaries of what is achievable in the realm of anticoagulant therapy, fostering a culture of innovation and excellence.
Conclusion:
In conclusion, Richard John Lindmark stands as a testament to the power of innovation and the profound influence that one individual can have on shaping the future of healthcare. His dedication to advancing anticoagulant therapy through inventive solutions continues to inspire generations of innovators to pursue excellence and make a tangible difference in the world.